A Randomized, Double Dummy, Parallel Arm, Placebo and Active Controlled, Double Blind, Study of the Safety and Efficacy of PRX167700 as Monotherapy in Adults with Moderate to Severe Knee Pain Due to Osteoarthritis who are Inappropriate for Oral Non steroidal Anti inflammatory Therapy.
Latest Information Update: 30 Jul 2020
At a glance
- Drugs PRX 167700 (Primary) ; Tramadol
- Indications Pain
- Focus Therapeutic Use
- Sponsors Proximagen
- 30 Jul 2020 This trial has been discontinued in United Kingdom
- 18 Jun 2019 New trial record